1. Home
  2. ATHE vs VRME Comparison

ATHE vs VRME Comparison

Compare ATHE & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • VRME
  • Stock Information
  • Founded
  • ATHE 1997
  • VRME 1999
  • Country
  • ATHE Australia
  • VRME United States
  • Employees
  • ATHE N/A
  • VRME N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • VRME EDP Services
  • Sector
  • ATHE Health Care
  • VRME Technology
  • Exchange
  • ATHE Nasdaq
  • VRME Nasdaq
  • Market Cap
  • ATHE 21.4M
  • VRME 17.5M
  • IPO Year
  • ATHE N/A
  • VRME N/A
  • Fundamental
  • Price
  • ATHE $4.75
  • VRME $1.29
  • Analyst Decision
  • ATHE Strong Buy
  • VRME Buy
  • Analyst Count
  • ATHE 2
  • VRME 1
  • Target Price
  • ATHE $8.00
  • VRME $1.50
  • AVG Volume (30 Days)
  • ATHE 1.3M
  • VRME 13.2M
  • Earning Date
  • ATHE 02-15-2025
  • VRME 03-20-2025
  • Dividend Yield
  • ATHE N/A
  • VRME N/A
  • EPS Growth
  • ATHE N/A
  • VRME N/A
  • EPS
  • ATHE N/A
  • VRME N/A
  • Revenue
  • ATHE $2,681,669.00
  • VRME $25,259,000.00
  • Revenue This Year
  • ATHE N/A
  • VRME N/A
  • Revenue Next Year
  • ATHE N/A
  • VRME $5.00
  • P/E Ratio
  • ATHE N/A
  • VRME N/A
  • Revenue Growth
  • ATHE 2.63
  • VRME N/A
  • 52 Week Low
  • ATHE $1.00
  • VRME $0.58
  • 52 Week High
  • ATHE $5.87
  • VRME $5.00
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 75.45
  • VRME 42.47
  • Support Level
  • ATHE $2.76
  • VRME $1.23
  • Resistance Level
  • ATHE $5.14
  • VRME $2.07
  • Average True Range (ATR)
  • ATHE 0.42
  • VRME 0.52
  • MACD
  • ATHE 0.15
  • VRME -0.22
  • Stochastic Oscillator
  • ATHE 71.14
  • VRME 0.96

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

Share on Social Networks: